Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C12N-001/00
C12N-001/22
C12N-001/14
C12N-005/00
C12N-005/02
출원번호
US-0576900
(2000-05-23)
발명자
/ 주소
Biddle, William C.
Fike, Richard M.
Dadey, Barbara M.
Bulera, Thomas E.
출원인 / 주소
Invitrogen Corporation
대리인 / 주소
Sterne, Kessler, Goldstein & Fox, P.L.L.C.
인용정보
피인용 횟수 :
17인용 특허 :
31
초록▼
The present invention relates generally to a method to reduce, substantially reduce, inactivate or eliminate adventitious agents and/or toxins in a sample, particuarly in nutritive media, media supplements, media subgroups and buffer formulations. Specifically, the present invention provides powdere
The present invention relates generally to a method to reduce, substantially reduce, inactivate or eliminate adventitious agents and/or toxins in a sample, particuarly in nutritive media, media supplements, media subgroups and buffer formulations. Specifically, the present invention provides powdered nutritive media, media supplements and media subgroups produced by the methods of the invention, particuarly cell culture media supplements (including powdered sera such as powdered fetal bovine serum (FBS)). The invention further provides powdered buffer formulations produced by the methods of the invention. The invention also provides kits and methods for cultivation of prokaryotic and eukaryotic cells, particularly bacterial cells, yeast cells, plant cells and animal cells (including human cells) using these nutritive media, media supplements, media subgroups and buffer formulations. The invention also relates to methods for producing storage stable cells having reduced, substantially reduced or eliminated adventitious agents or toxins.
대표청구항▼
1. A method for reducing one or more adventitious agents or toxins in a sample, said method comprising subjecting a powdered sample to fluid bed agglomeration under conditions sufficient to reduce one or more adventitious agents or one or more toxins in said sample; wherein said powdered sample i
1. A method for reducing one or more adventitious agents or toxins in a sample, said method comprising subjecting a powdered sample to fluid bed agglomeration under conditions sufficient to reduce one or more adventitious agents or one or more toxins in said sample; wherein said powdered sample is selected from the group consisting of yeast culture media, plant culture media, animal culture media and buffers; and wherein said one or more toxins are selected from the group consisting of endotoxin, exotoxins, snake or animal venom, cholera toxin, leukocidin, Ricin A, poisons derived from animals, neurotoxin, and erythrogenic toxin. 2. The method of claim 1, wherein said fluid bed agglomeration comprises: (a) subjecting said powdered sample to suspension in a moving column of a gas or combination of gases; (b) injecting one or more solvents into said powdered sample to produce a moistened powder; and (c) drying the moistened powder to produce a dried agglomerated sample. 3. The method of claim 2, wherein said powdered sample is heated. 4. The method of claim 2, wherein said gas or combination of gases is heated. 5. The method of claim 2, further comprising passing said powdered sample through one or more filters. 6. The method of claim 1, wherein said powdered sample comprises one or more components selected from the group consisting of serum, L-glutamine, cystine, insulin, transferrin, lipid, carbohydrate, cytokine, neurotransmitter and sodium bicarbonate. 7. The method of claim 2, wherein said gas or combination of gases are toxic or inhibitory to said one or more adventitious agents, or inhibitory to said one or more toxins. 8. The method of claim 2, wherein said gas or combination of gases is selected from the group consisting of nitrogen, helium, air, carbon dioxide, argon, oxygen, and hydrogen. 9. The method of claim 2, wherein said one or more solvents are toxic or inhibitory to said one or more adventitious agents, or inhibitory to said one or more toxins. 10. The method of claim 2, wherein said one or more solvents are selected from the group consisting of: water; serum; organic solvents; blood derived products; extracts or hydrolysates of tissues, organs, glands or cells; animal derived products; media supplements; buffers; acids and bases. 11. The method of claim 10, wherein said one or more solvents contain one or more additional components selected from the group consisting of salts, polysaccharides, ions, detergents and stabilizers. 12. The method of claim 2, wherein said one or more solvents have incorporated into them one or more components selected from the group consisting of serum, hormones, cytokines, neurotransmitters, lipids, carbohydrates, attachment factors, proteins, amino acids, vitamins and enzyme cofactors. 13. The method of claim 1, wherein said adventitious agents are selected from the group consisting of animal, human, plant, fish, insect, and mammalian viruses. 14. The method of claim 1, wherein said buffers are selected from the group consisting of phosphate-buffered saline and tris-buffered saline. 15. The method of claim 1, wherein said powdered sample is a yeast culture medium. 16. The method of claim 1, wherein said powdered sample is a plant culture medium. 17. The method of claim 1, wherein said powdered sample is an animal culture medium. 18. The method of claim 1, wherein said powdered sample is a buffer. 19. The method of claim 18, wherein said buffer is selected from the group consisting of phosphate-buffered saline and tris-buffered saline.
Chrisope Gerald L. (Lake Charles LA) Roberts Nell C. (Lake Charles LA), Apparatus for methods for preserving, transporting storing, re-hydrating and delivering viable micro-organisms.
Christensen Mogens (Virum DKX) Madsen Benny (Horsens DKX) Bonde Mikael (Basel CHX), Bed plate for a fluidized bed apparatus and a method for making the same.
Prestrelski Steven J. (1971 W. Middlefield Rd. ; Unit #5 Mountain View CA 94043) Zhang Mei Z. (444 Via Colinas Thousand Oaks CA 91362), Formulation of a reconstituted protein, and method and kit for the production thereof.
Schmitthaeusler Roland (Montigny-le-Bretonneux FRX) Bardat Annie (Limours FRX), Method for decontaminating or sterilizing “in situ”a vacuum sealed container and device for implementing such method.
Sutton Andrew D. (Ruddington GB2) Johnson Richard A. (West Bridgford GB2) Senior Peter J. (Near Melbourne GB2) Heath David (The Park GB2), Preparation of diagnostic agents.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.